SCA
ABBV icon

Southern Capital Advisors’s AbbVie ABBV Stock Holding History

Southern Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
1,211
+2
+0.2% +$430 0.13% 64
2026
Q1 		$263K Buy
1,209
+1
+0.1% +$222 0.12% 74
2025
Q4 		$276K Sell
1,208
-14
-1% -$3.19K 0.13% 70
2025
Q3 		$283K Buy
1,222
+2
+0.2% +$407 0.13% 67
2025
Q2 		$226K Buy
1,220
+2
+0.2% +$372 0.12% 73
2025
Q1 		$255K Sell
1,218
-12
-1% -$2.33K 0.14% 67
2024
Q4 		$219K Buy
1,230
+39
+3% +$7.17K 0.12% 66
2024
Q3 		$235K Buy
+1,191
New +$222K 0.13% 65

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Southern Capital Advisors's ABBV Position: Q2 2026 in Review

Southern Capital Advisors increased its AbbVie (ABBV) stake by 0.17% in Q2 2026, buying an estimated $430 and bringing the position to 1,211 shares worth $305K. The position accounts for 0.13% of the portfolio, ranked #64.

Southern Capital Advisors first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Southern Capital Advisors held 1,211 shares of AbbVie worth $305K as of Q2 2026.
  • Southern Capital Advisors bought 2 AbbVie shares in Q2 2026, an estimated $430.
  • AbbVie made up 0.13% of Southern Capital Advisors's portfolio in Q2 2026, its #64 holding.
  • Southern Capital Advisors first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • 2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Southern Capital Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.